Pancreas exocrin. Pancreas endocrin. Pancreatite acute Pancreatite cronice Afectiuni ereditare ale pancreasului Tumori pancreatice

Size: px
Start display at page:

Download "Pancreas exocrin. Pancreas endocrin. Pancreatite acute Pancreatite cronice Afectiuni ereditare ale pancreasului Tumori pancreatice"

Transcription

1

2 Pancreas exocrin Pancreatite acute Pancreatite cronice Afectiuni ereditare ale pancreasului Tumori pancreatice Pancreas endocrin Diabetul zaharat Tumorile neuroendocrine PET-NET

3 Pancreas exocrin Pancreatite acute Pancreatite cronice Afectiuni ereditare ale pancreasului Tumori pancreatice Pancreas endocrin Diabetul zaharat Tumorile neuroendocrine PET-NET

4 Pancreatita acuta urgenta garda UPU Pancreatita cronica durere abdominala trenanta Medic de familie! Chirurg sau Internist Tumori pancreatice Eventual internist din policlinica Nutritionist, medic de familie, endocrinolog, psihiatru, gastroenterolog 4

5 Necesita explorari Uneori sofisticate Necesara internare De obicei gastroenterolog 5

6 Incidenta 4,9-35 %ooo /an In crestere in tarile europene Cauza majora de spitalizare in SUA Cauza = crester consum de alcool Mortalitate 5-17% Vege SS et al Gastrointestinal epidmiology 2007

7 Incidence of AP increased between 2000 and 2005 from 13.2 to 14.7 Incidence of AP for males increased from 13.8 to 15.2, for females from 12.7 to 14.2 Mortality for AP fluctuated between 6.9 and 11.7 per million persons/ year and was almost similar for males and females. Incidence and mortality of AP and CP increased markedly with age. CONCLUSION: Incidence of AP steadily increased. Mortality for AP remained fairly stable. Patient burden and health care costs probably will increase because of an ageing BW Ml Spanier et alworld J Gastroenterol 2013 May 28; 19(20):

8 European studies increase in the incidence rate of acute pancreatitis 922 patients with confirmed diagnosis of AP ( ( )in 1 hospital incidence rate varied from 24 to 35/ inhabitants annually. Mean age was 60 ± 16 years. 53% men and 47% women etiologies of AP were biliary stones in 60% and alcohol abuse in 19% of patients. severe in 50% and 43 Davor Stimac et al - Gastroenterology Research and Practice Volume 2013, Article ID ,

9 Cauza Pancreatita cronica Fibroza chistica Chirurgia pancreatica Prevalenta 3,9/ EU 3,3/ Franta 4,2 / Germania 2,9/ Italia 3.0/ Spania 5,5/ UK Mattson,Jakc Report Pancreatic exocrine insuffiency epidemiology

10 Loss of functioning parenchyma Chronic pancreatitis Cystic Fibrosis Tumours Resections secretion despite intact parenchyma Obstruction endogenous stimulation (coeliac, Crohns, DM) Asynchrony Gastric resections Short bowel syndrome Crohns, DM Enzyme inactivation Zollinger-Ellison syndrome

11 Prevalenta Creste cu varsta Mai mare la barbati Distributia pe sex si varsta difera f de etiologie Alcoolica mai frecv la Barbati Idiopatica si hiperlipemica la femei Fiborza chistica egala femei barbati Fibroza chistica mai frecv in primul an de viata Pancreatita cronica si chirurgie la varstnic Rothenbacher D, etal Scand J Gast 2005;40(6)

12 Insuficienta pancreatica exocrina Pancreatita cronica Pancreatita senila Pancreatita acuta Cauze Rezectie gastrica Fibroza chistica Pancreatectomie Indicatie PEI Plenitudine Meteorism Steatoree Dispepsie Semne simptome Greata / varsaturi Pierderea apetitului Malabsortie Intoleranta alimentelor Pierdere in greutate Durere abdominala

13 Pancreatita cronica PA Forma usoara Forma severa Pseudochist Recidiva Restitutio ad integrum PA Pancreatita acuta PC Incidenta PC este de 3,5-4 / locuitori. Prevalenta/Predominanta de vârsta si sex: pancreatita cronica afecteaza preponderent barbatii în vârsta de ani (de 3 ori mai frecventa decât la femei). PC Pancreatita cronica Klöppel & Maillet, Hepatogastroenterol 38:408, 1991

14 INCIDENTA = 3-10 %ooo loc PREVALENTA = %ooo loc!!este in crestere Variaza geografic Tara Incidenta / loc Sursa Japonia 5.7 JGastroenterol 38(4):315-26, 2003 Elvetia 1.6 Eur J Gastroenterol Hepatol.13(6):749-50, 2001 Finlanda 23 Pancreatology.2(5): , 2002 Cehia 7.9 idem 14

15 Inciența este de 6-7 / locuitori în vest 80% sex masculin. Vârsta medie depinde de etiologie, ~ ani la PC alcoolică, ~ la PC idiopatică, ~ la cei PC ereditară, ~ 10 ani la copii cu PC tropicală. Incidența este crescută la negri față de albi. James Jupp a,1, David Fine b,2, ColinD.Johnson c,*best Practice&ResearchClinicalGastroenterology24(2010)219e231

16 Etiologie. Consumul excesiv de alcool 70-85% Fumatul, l factor de risc extern cancerului pancreatic. Alte cauze rare de PC: hipercalcemia peste 12mg/dl (3mmol/l (1% din PC sunt datorate hiperpth, 7% din hiperpth au și PC). PC tropicală. PC genetică. PC autoimună PC obstructivă. PC idiopatică. 10% din cazurile de PC James Jupp a,1, David Fine b,2, ColinD.Johnson c,*best Practice&ResearchClinicalGastroenterology24(2010)219e231

17 Benigne Maligne Epiteliale Nonepiteliale Exocrine Endocrine

18 Epithelial tumours Benign Serous cystadenoma 8441/01 Mucinous cystadenoma 8470/0 Intraductal papillary-mucinous adenoma 8453/0 Mature teratoma 9080/0 Borderline (uncertain malignant potential) Mucinous cystic neoplasm with moderate dysplasia 8470/1 Intraductal papillary-mucinous neoplasm with moderate dysplasia Solid-pseudopapillary neoplasm 8452/1 Malignant Ductal adenocarcinoma 8500/3 Mucinous noncystic carcinoma 8480/3 Signet ring cell carcinoma 8490/3 Adenosquamous carcinoma 8560/3 Undifferentiated (anaplastic) carcinoma 8020/3 Undifferentiated carcinoma with osteoclast-like giant cells 8035/3 Mixed ductal-endocrine carcinoma 8154/3 Serous cystadenocarcinoma 8441/3 Mucinous cystadenocarcinoma 8470/3 non-invasive 8470/2 invasive 8470/3 Intraductal papillary-mucinous carcinoma 8453/3 non-invasive 8453/2 invasive (papillary-mucinous carcinoma) 8453/3 Acinar cell carcinoma 8550/3 Acinar cell cystadenocarcinoma 8551/3 Mixed acinar-endocrine carcinoma 8154/3 Pancreatoblastoma 8971/3 Solid-pseudopapillary carcinoma 8452/3 Others Non-epithelial tumours Secondary tumours

19 Primary Tumour (T) TX Primary tumour cannot be assessed T0 No evidence of primary tumour Tis Carcinoma in situ T1 Tumour limited to the pancreas, 2 cm or less in greatest dimension T2 Tumour limited to the pancreas, more than 2 cm in greatest dimension T3 Tumour extends directly into any of the following: duodenum, bile duct, peripancreatic tissues3 T4 Tumour extends directly into any of the following: stomach, spleen, colon, adjacent large vessels4 Regional Lymph Nodes (N) NX Regional lymph nodes cannot be assessed N0 No regional lymph node metastasis N1 Regional lymph node metastasis N1a Metastasis in a single regional lymph node N1b Metastasis in multiple regional lymph nodes Distant Metastasis (M) MX Distant metastasis cannot be assessed M0 No distant metastasis MI Distant metastasis Stage grouping Stage 0 Tis N0 M0 Stage I T1 N0 M0 T2 N0 M0 Stage II T3 N0 M0 Stage III T1 N1 M0 T2 N1 M0 T3 N1 M0 Stage IVA T4 Any N M0 Stage IVB Any T Any N M1

20 Malvezi M et al - Annals of Oncology 28 feb 2012 Sex Cancer Recorded deaths 2007 Predicted number of deaths 2012 Men Stomach colon and rectum Pancreas Lung Prostate Leukemias All cancers (malignant and benign) Women Stomach Colon and rectum Pancreas Lung Breast Uterus (cervix and corpus) Leukemias All cancers (malignant and benign)

21

22 10th most frequent cancer the 8th leading cause of cancer-related death Incidence men: 7,3 8,7 per women: 4,5 5,7 per >95% of patients are dying of their disease No survival increases have been observed in the last years S. Cascinu et al. Annals of Oncology 21 (Supplement 5): v55 v58, 2010

23 Demographic factors Old age (most reliable and important predictor) Sex (more common in males than in females) Ethnic origin (mortality highest in black populations) Genetic factors and medical conditions Family history (one first degree 2,3 fold increased risk) Hereditary pancreatitis Hereditary non-polyposis colorectal cancer Ataxia-telangiectasia Peutz-Jeghers syndrome (132 fold increased risk) Familial breast cancer (BRCA2 mutations) Familial atypical multiple mole melanoma (germline mutations in p16) Chronic pancreatitis (2% per decade) Diabetic mellitus Gastrectomy Deficiency in carcinogen metabolism and DNA repair Environmental and lifestyle factors Cigarette smoking Occupational exposures Low dietary intake of fruits and vegetables Food preparation and cooking methods (grilling or charring confers the highest risk) James L Abbruzzese et al. Lancet 2004; 363:

24 Enviromental factors cigarette smoking* RR = at least 1,5 especially in smokers with GSTT1 (homozygous deletions of gene glutathione S-transferase T1) risk level returns to baseline by 15 years after cessation dietary** excessive fat or meat diabetes mellitus*** diagnosed within the preceding two years associated with obesity *Ghadirian P. Cancer 1991; 67: **Farrow DC. Am J Epidemiol 1990; 132: ***Gullo L. N Engl J Med 1994; 331:81-4

25 Normal pancreas has 3 types of epithelial cells Acinar cells 80% Ductal cells 10-15% Endocrine cells - <5% 95% of neoplasms arise from the exocrine elements - ductal and acinar cells Ductal adenocarcinoma = 85% to 90% of pancreatic tumors Localization: 60-70% head, 5-10% body,10-15% tail

26 Benign Serous cystadenoma Mucinous cystadenoma Intraductal papillary mucinous adenoma Mature cystic teratoma Borderline (uncertain malignant potential) Mucinous cystic tumor with moderate dysplasia Intraductal papillary mucinous tumor with moderate dysplasia Solid-pseudopapillary tumor Malignant Ductal adenocarcinoma Osteoclast-like giant cell tumor Serous cystadenocarcinoma Mucinous cystadenocarcinoma (noninvasive or invasive) Intraductal papillary mucinous carcinoma (noninvasive or invasive) Acinar cell carcinoma Pancreatoblastoma Solid-pseudopapillary carcinoma Miscellaneous carcinomas Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC

27 successive accumulation of gene mutations 3 precursor lesions*: Primary histologic precursor of pancreatic cancer = pancreatic intraductal neoplasia (PanIN) PanIN 1a,b (minimally dysplastic epithelium) pancreatic ** activation of the KRAS2 oncogene, inactivation of the tumor-suppressor gene CDKN2A inactivation of the tumor-suppressor genes TP53 and deleted in cancer 4 (DPC4, also known as the SMAD4 PanIN 2,3 (severe dysplasia) Mucinous cystic neoplasm (MCN) intraductal pancreatic mucinous neoplasm (IPMN) * Jason Klapman. Cancer Control October 2008, Vol. 15, No. 4 ** Feldmann G. J Hepatobiliary Pancreat Surg 2007;14:224-32

28 Normal duct PanIN Ia PanIN Ib PanIN II PanIN III Cancer MCN low grade Normal duct Intermediate grade High grade IPMN low grade Jason Klapman. Cancer Control October 2008, Vol. 15, No. 4

29 Gene/ chromosomal region (oncogenes and tumor supression) K-ras (12p) >90% p16 CDKN2A (9p) >95% PK53 (17p) 50%-70% SMAD4/DPC4 (18q) 55% AKT2 (19q) 10%-20% MYB (6q) 10% AIB1 (20q) 10% BRCA2 (13q) 7%-10% LKB1/STK11 (19p) <5% MKK4 (17p) <5% TGF-β-R1 (9q) or TGF-β-R2 (3p) <5% RB1 (13q) <5% % of tumors with genetic mutation Modified from Hruban RH, Wilentz RE. The pancreas. In: Kumar V, Abbas AK, Fausto N, editors. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia: Elsevier; 2005

30 Oncogenes K-ras present in 90% of cancers frequency of mutations = extent of dysplasia Can be detected in chronic pancreatitis without neoplasia Tumor suppressor genes TP53 mutations chromosomal instability cancer P16 mutation associated with FAMMM syndrome (melanoma and pancreatic cancer) associated with decreased survival DPC4 = effect on cell cycle regulation and cell differentiation Other: up-regulation of EGF, telomere shortening

31

32 Cancer Incidence Oesophagus 578 Stomach 2650 Colorectum 4554 Liver 1279 Gallbladder 293 Pancreas 1682 Lung 8387 Prostate 3620

33 Cancer Incidence Oesophagus 103 Stomach 1351 Colorectum 4142 Liver 692 Gallbladder 355 Pancreas 1184 Breast 7929 Cervix uteri 3402 Corpus uteri 1208 Ovary 1686

34 Male Female both Lung Breast Lung Colorectum Colorectum Colorectum Prostate Cervix uteri Breast Stomach Lung Stomach Bladder Ovary Prostate Romania GLOBOCAN 2008

35 Statisitica MS PCR in cazuri = 4,8 %ooo locuitori Studii Diculescu et al Romanian J gastroenterol 2005 studiu de cohorta PAC 62 pacienti sp Elias Hajjar N et al Chirurgia pacienti Chirurgie 3 Cluj Hecser L et al Rom J Legal Med2009 case reports PAC Diaconu B J Gastrointest Liver Disease 2009 SPINK 1 mutatie in 94 pac cu PCR

36 Cauze Raportarea in functie de ICM/DRG modifica formularea diagnostica Raportarea in teritoriu deficitara Patologie complexa ce implica multe esaloane medicale ( primara, secundara tertiare) fiecare cu raportari diferite

37 Dezavantaje Simptomatologia in patologia pancreatica apare de f multe ori f tardiv in stadii avansate Diagnosticul se bazeaza pe explorari imagistice sofisticate inabordabila pt metode de screening Avantaje Pancreatitele acute se interneaza doar in spitalele de urgenta Rata incidentei in tumorile maligne pancreatica este practic egala cu cea a mortalitatii Putine cazuri de Pancreatite cronice

38 Abord multidiscliplinar Standardizarea diagnosticelor APPR => registre pe domenii restranse de cazuri Pancreatite ereditare Tumori pancreatice rare Tumori neuroendocrine (PET-NET)

39 Incidenta pancreatitelor acute este in crestere in tarile occidentale ( si la noi?) Cunoasterea corecta a abordarii PAC poate salva vieti Pancreatitele cronice sunt subdiagnosticate si subestimate Tumorile pancreatice sunt in crestere si nu sunt metode de screening eficient actual

Appendix 4: WHO Classification of Tumours of the pancreas 17

Appendix 4: WHO Classification of Tumours of the pancreas 17 S3.01 The WHO histological tumour type must be recorded. CS3.01a The histological type of the tumour should be recorded based on the current WHO classification 17 (refer to Appendices 4-7). Appendix 4:

More information

Pancreatic intraepithelial

Pancreatic intraepithelial Pancreatic intraepithelial neoplasia (PanIN) Markéta Hermanová St. Anne s University Hospital Brno Faculty of Medicine, Masaryk University Precursor lesions of invasive pancreatic cancer Pancreatic intraepithelial

More information

Pancreatic Cytopathology: The Solid Neoplasms

Pancreatic Cytopathology: The Solid Neoplasms Pancreatic Cytopathology: The Solid Neoplasms Syed Z. Ali, M.D. Professor of Pathology and Radiology Director of Cytopathology The Johns Hopkins Hospital Baltimore, Maryland Pancreatic Cytopathology: Past,

More information

Genetics of Pancreatic Cancer. October 6, If you experience technical difficulty during the presentation:

Genetics of Pancreatic Cancer. October 6, If you experience technical difficulty during the presentation: Genetics of Pancreatic Cancer October 6, 2016 If you experience technical difficulty during the presentation: Contact WebEx Technical Support directly at: US Toll Free: 1-866-229-3239 Toll Only: 1-408-435-7088

More information

Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas.

Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas. Pancreas (Exocrine) Protocol applies to all carcinomas of the exocrine pancreas. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Procedures Cytology (No Accompanying Checklist)

More information

Neoplasias Quisticas del Páncreas

Neoplasias Quisticas del Páncreas SEAP -Aproximación Práctica a la Patología Gastrointestinal- Madrid, 26 de mayo, 2006 Neoplasias Quisticas del Páncreas Gregory Y. Lauwers, M.D. Director, Service Massachusetts General Hospital Harvard

More information

Select problems in cystic pancreatic lesions

Select problems in cystic pancreatic lesions Disclosure Select problems in cystic pancreatic lesions Five Prime Therapeutics shareholder Adicet Bio shareholder Bristol-Meyer Squibb advisory board grace.kim@ucsf.edu Pancreatic cystic lesions Intraductal

More information

Pancreatic Cysts. Darius C. Desai, MD FACS St. Luke s University Health Network

Pancreatic Cysts. Darius C. Desai, MD FACS St. Luke s University Health Network Pancreatic Cysts Darius C. Desai, MD FACS St. Luke s University Health Network None Disclosures Incidence Widespread use of cross sectional imaging Seen in over 2% of patients having abdominal imaging

More information

p53 expression in invasive pancreatic adenocarcinoma and precursor lesions

p53 expression in invasive pancreatic adenocarcinoma and precursor lesions Malaysian J Pathol 2011; 33(2) : 89 94 ORIGINAL ARTICLE p53 expression in invasive pancreatic adenocarcinoma and precursor lesions NORFADZILAH MY MBBCH,* Jayalakshmi PAILOOR MPath, FRCPath,* RETNESWARI

More information

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts)

Pancreas Quizzes c. Both A and B a. Directly into the blood stream (not using ducts) Pancreas Quizzes Quiz 1 1. The pancreas produces hormones. Which type of hormone producing organ is the pancreas? a. Endocrine b. Exocrine c. Both A and B d. Neither A or B 2. Endocrine indicates hormones

More information

Surveillance of Individuals At High Risk For Developing Pancreatic Cancer

Surveillance of Individuals At High Risk For Developing Pancreatic Cancer Surveillance of Individuals At High Risk For Developing Pancreatic Cancer Marco Bruno Erasmus Medical Center, Rotterdam Pancreatic Cancer Facts & figures One of the most fatal malignancies Overall 5-year

More information

Pancreatic Cancer: The ABCs of the AJCC and WHO

Pancreatic Cancer: The ABCs of the AJCC and WHO Pancreatic Cancer: The ABCs of the AJCC and WHO Aatur D. Singhi, MD PhD Assistant Professor University of Pittsburgh Medical Center Department of Pathology singhiad@upmc.edu Case presentation Objectives

More information

PANCREAS DUCTAL ADENOCARCINOMA PDAC

PANCREAS DUCTAL ADENOCARCINOMA PDAC CONTENTS PANCREAS DUCTAL ADENOCARCINOMA PDAC I. What is the pancreas? II. III. IV. What is pancreas cancer? What is the epidemiology of Pancreatic Ductal Adenocarcinoma (PDAC)? What are the risk factors

More information

An Approach to Pancreatic Cysts. Introduction

An Approach to Pancreatic Cysts. Introduction An Approach to Pancreatic Cysts Nalini M. Guda, MD Aurora St. Luke s Medical Center, Milwaukee Clinical Adjunct Professor of Medicine, University of Wisconsin School of Medicine and Public Health Introduction

More information

Evaluation and Management of Cystic Lesions of the Pancreas: When to Resect, When to Follow and When to Forget

Evaluation and Management of Cystic Lesions of the Pancreas: When to Resect, When to Follow and When to Forget Evaluation and Management of Cystic Lesions of the Pancreas: When to Resect, When to Follow and When to Forget Randall Brand, MD Professor of Medicine Division of Gastroenterology, Hepatology and Nutrition

More information

incidence rate x 100,000/year

incidence rate x 100,000/year Tier R=rare C=common Cancer Entity European crude and age adjusted incidence by cancer, years of diagnosis 2000 and 2007 Analisys based on 83 population-based cancer registries * applying the European

More information

Epidemiology and genetics of pancreatic cancer

Epidemiology and genetics of pancreatic cancer 1 Epidemiology and genetics of pancreatic cancer Srinivasa K. R. Prasad and Rong Zeng Introduction Pancreatic ductal adenocarcinoma (and its histological variants), also referred to as pancreatic cancer

More information

Pancreatic Cystic Lesions 원자력병원

Pancreatic Cystic Lesions 원자력병원 Pancreatic Cystic Lesions 원자력병원 박선 후 Lines of cellular differentiation Ductal Acinar Undetermined Ductal adenocarcinoma Serous/ mucinous tumor Intraductal papillary mucinous neoplasm Acinar cell carcinoma

More information

Intraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS

Intraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS Intraductal Papillary Mucinous Neoplasms: We Still Have a Way to Go! Francesco M. Serafini, MD, FACS Brooklyn VAMC September 21 st GI Grand Rounds - What is it? - Clinical entity that has emerged from

More information

40th European Congress of Cytology Liverpool, UK, 2-5 th October 2016

40th European Congress of Cytology Liverpool, UK, 2-5 th October 2016 40th European Congress of Cytology Liverpool, UK, 2-5 th October 2016 EUS FNA of abdominal organs: An approach to reporting and triage for ancillary testing Date and time: Sunday 2 nd October 2016 15.00-16.30

More information

Anatomy of the biliary tract

Anatomy of the biliary tract Harvard-MIT Division of Health Sciences and Technology HST.121: Gastroenterology, Fall 2005 Instructors: Dr. Jonathan Glickman Anatomy of the biliary tract Figure removed due to copyright reasons. Biliary

More information

H&E, IHC anti- Cytokeratin

H&E, IHC anti- Cytokeratin Cat No: OVC2281 - Ovary cancer tissue array Lot# Cores Size Cut Format QA/QC OVC228101 228 1.1mm 4um 12X19 H&E, IHC anti- Cytokeratin Recommended applications: For Research use only. RNA or protein ovary

More information

Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis

Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/combatting-pancreatic-cancer-keys-earlyrecognition-and-diagnosis/7286/

More information

The Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System

The Pancreas. Basic Anatomy. Endocrine pancreas. Exocrine pancreas. Pancreas vasculature. Islets of Langerhans. Acinar cells Ductal System SGNA: Back to Basics Rogelio G. Silva, MD Assistant Clinical Professor of Medicine University of Illinois at Chicago Department of Medicine Division of Gastroenterology Advocate Christ Medical Center GI

More information

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar Link full download: http://testbankair.com/download/test-bank-for-robbins-cotran-pathologic-basis-of-disease-9th-edition-bykumar-abbas-and-aster Test Bank for Robbins and Cotran Pathologic Basis of Disease

More information

Hepatobiliary and Pancreatic Malignancies

Hepatobiliary and Pancreatic Malignancies Hepatobiliary and Pancreatic Malignancies Gareth Eeson MD MSc FRCSC Surgical Oncologist and General Surgeon Kelowna General Hospital Interior Health Consultant, Surgical Oncology BC Cancer Agency Centre

More information

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar

Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th Edition by Kumar Link full download:https://getbooksolutions.com/download/test-bank-for-robbinsand-cotran-pathologic-basis-of-disease-9th-edition-by-kumar Test Bank for Robbins and Cotran Pathologic Basis of Disease 9th

More information

The international health care burden of cancers of the gastrointestinal tract and liver

The international health care burden of cancers of the gastrointestinal tract and liver The international health care burden of cancers of the gastrointestinal tract and liver William R. Brown 1*, Dennis J. Ahnen 2 1 Department of Medicine, University of Colorado School of Medicine, Denver,

More information

Pancreas Cancer Genomics

Pancreas Cancer Genomics Pancreas Cancer Genomics Steven Gallinger MD, MSc, FRCS HPB Surgical Oncology Program University Health Network Samuel Lunenfeld Research Institute Mount Sinai Hospital University of Toronto Fate of the

More information

Pancreatobiliary Frozen Section Nightmares

Pancreatobiliary Frozen Section Nightmares Pancreatobiliary Frozen Section Nightmares Aatur D. Singhi, MD PhD Assistant Professor University of Pittsburgh Medical Center Department of Pathology singhiad@upmc.edu Objectives Briefly give an overview

More information

Standardized Terminology in Pancreatobiliary Cytology: The Papanicolaou Society Guidelines

Standardized Terminology in Pancreatobiliary Cytology: The Papanicolaou Society Guidelines Standardized Terminology in Pancreatobiliary Cytology: The Papanicolaou Society Guidelines Barbara Ann Centeno. M.D. Vice-Chair, Clinical Services, Anatomic Pathology Assistant Chief, Pathology Service

More information

CYTOLOGY OF EUS- GUIDED FNA OF THE PANCREAS AND THE UPPER GI TRACT

CYTOLOGY OF EUS- GUIDED FNA OF THE PANCREAS AND THE UPPER GI TRACT CYTOLOGY OF EUS- GUIDED FNA OF THE PANCREAS AND THE UPPER GI TRACT Barbara A. Centeno, M.D. Vice-Chair, Clinical Services Assistant Chief of Pathology Director of Cytopathology Department of Anatomic Pathology/Moffitt

More information

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14 Contents 14. Neuroendocrine Tumours 161 14.1. Diagnostic algorithm

More information

Tumour Structure and Nomenclature. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Tumour Structure and Nomenclature. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge Tumour Structure and Nomenclature Paul Edwards Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge Malignant Metastasis Core idea of cancer Normal Cell Slightly

More information

7th Annual Symposium on Gastrointestinal Cancers " St. Louis, Mo, 9/20/08

7th Annual Symposium on Gastrointestinal Cancers  St. Louis, Mo, 9/20/08 Molecular markers to aid in early diagnosis of pancreatic cancer Michael Goggins, MD Professor of Pathology, Medicine and Oncology Johns Hopkins Medical Institutions, Baltimore, MD 7th Annual Symposium

More information

Overview of 2010 Hong Kong Cancer Statistics

Overview of 2010 Hong Kong Cancer Statistics Overview of 2010 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since the 1960s been providing population-based cancer data for epidemiological research

More information

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds

Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Dr Claire Smith, Consultant Radiologist St James University Hospital Leeds Imaging in jaundice and 2ww pathway Image protocol Staging Limitations Pancreatic cancer 1.2.4 Refer people using a suspected

More information

Kenneth D. Chi, MD Medical Director GI Lab Advocate Lutheran General Hospital

Kenneth D. Chi, MD Medical Director GI Lab Advocate Lutheran General Hospital Kenneth D. Chi, MD Medical Director GI Lab Advocate Lutheran General Hospital Advances in Digestive Health for the Primary Care Physician Symposium May 2, 2015 None Case Presentation Types of Pancreatic

More information

The pathology of pancreas

The pathology of pancreas 5. Practice The pathology of pancreas 2017/2018. 2nd semester MACROSCOPY- MICROSCOPY THE STRUCTURE OF PANCREAS Exocrine: 80-85% Enzymes in the zymogenic granules of acinar cells: trypsin, chymotrypsin,

More information

Collecting Cancer Data: Pancreas

Collecting Cancer Data: Pancreas Collecting Cancer Data: Pancreas NAACCR 2011 2012 Webinar Series 1/5/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this

More information

Neuro-endocrine and pancreatic non-adenocarcinomas. Marc Engelbrecht, AMC, Amsterdam

Neuro-endocrine and pancreatic non-adenocarcinomas. Marc Engelbrecht, AMC, Amsterdam Neuro-endocrine and pancreatic non-adenocarcinomas Marc Engelbrecht, AMC, Amsterdam Pancreatic Tumors q Epithelial Exocrine q Mesenchymal Ductal Adenocarcinoma (85-95%) Metastasis Lymfoma Acinar Cell Carcinoma

More information

GASTROINTESTINAL IMAGING STUDY GUIDE

GASTROINTESTINAL IMAGING STUDY GUIDE GASTROINTESTINAL IMAGING STUDY GUIDE Pharynx Diverticula Foreign bodies Trauma o Motility Disorders Esophagus Diverticula Trauma Esophagitis Barrett esophagus Rings, webs, and strictures Varices Benign

More information

Radiology Pathology Conference

Radiology Pathology Conference Radiology Pathology Conference Nadia F. Yusaf, M.D. PGY-3 1/29/2010 Presentation material is for education purposes only. All rights reserved. 2010 URMC Radiology Page 1 of 90 Case 1 60 year- old man presents

More information

Morphologic features in cystic lesions of pancreas-a retrospective analysis

Morphologic features in cystic lesions of pancreas-a retrospective analysis International Journal of Advances in Medicine Cicy PJ et al. Int J Adv Med. 2018 Feb;5(1):192-196 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20180083

More information

Matthew McCollough, M.D. April 9, 2009 University of Louisville

Matthew McCollough, M.D. April 9, 2009 University of Louisville Matthew McCollough, M.D. April 9, 2009 University of Louisville List the differential diagnosis for pancreatic cysts Review the epidemiology Illustrate the types of cysts through case discussions Discuss

More information

An investigation of pancreatic volume by disease using pancreatic volumetry

An investigation of pancreatic volume by disease using pancreatic volumetry Yamagata Med J (ISSN 0288-030X)2015;33(2):71-76 DOI 10.15022/00003469 An investigation of pancreatic volume by disease using pancreatic volumetry Tsuyoshi Fukumoto, Toshihiro Watanabe, Koji Tezuka, Akiko

More information

Cancer in Estonia 2014

Cancer in Estonia 2014 Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National

More information

Poblacions amb alt risc de càncer de pàncrees. Quin seguiment hem de fer?

Poblacions amb alt risc de càncer de pàncrees. Quin seguiment hem de fer? Poblacions amb alt risc de càncer de pàncrees. Quin seguiment hem de fer? T. Macarulla Hospital Vall d Hebrón Actualització en patologia pancreàtica Societat catalana de pàncrees-scpanc 4 Octubre 2016

More information

Pancreatic Cancer. BIOLOGY: Not well defined (genetic and enviromental factors) CLINICAL PRESENTATION: Abd pain, jaundice, weight loss.

Pancreatic Cancer. BIOLOGY: Not well defined (genetic and enviromental factors) CLINICAL PRESENTATION: Abd pain, jaundice, weight loss. EloreMed Editor: Le Wang, MD, PhD Date of Update: 2/6/2018 UpToDate: Liposomal irinotecan (Onivyde) plus FU/LV is now approved for gemcitabine-refractory metastatic pancreatic cancer and recommended by

More information

3 cell types in the normal ovary

3 cell types in the normal ovary Ovarian tumors 3 cell types in the normal ovary Surface (coelomic epithelium) the origin of the great majority of ovarian tumors (neoplasms) 90% of malignant ovarian tumors Totipotent germ cells Sex cord-stromal

More information

Management A Guideline Based Approach to the Incidental Pancreatic Cysts. Common Cystic Pancreatic Neoplasms.

Management A Guideline Based Approach to the Incidental Pancreatic Cysts. Common Cystic Pancreatic Neoplasms. Management 2016 A Guideline Based Approach to the Incidental Pancreatic Cysts ISMRM 2016 Masoom Haider, MD, FRCP(C) Professor of Radiology, University of Toronto Clinician Scientist, Ontario Institute

More information

Overview of 2009 Hong Kong Cancer Statistics

Overview of 2009 Hong Kong Cancer Statistics Overview of 2009 Hong Kong Cancer Statistics Cancer Registration in Hong Kong The Hong Kong Cancer Registry has since 1963 been providing population-based cancer data for epidemiological research and healthcare

More information

Causes of pancreatic insufficiency. Eugen Dumitru

Causes of pancreatic insufficiency. Eugen Dumitru Causes of pancreatic insufficiency Eugen Dumitru Pancreatic Exocrine Insufficiency (PEI) 1. The Concept 2. The Causes 3. The Consequences Pancreatic Exocrine Insufficiency (PEI) 1. The Concept 2. The Causes

More information

Recommendations for the Reporting of Pancreatic Specimens Containing Malignant Tumors

Recommendations for the Reporting of Pancreatic Specimens Containing Malignant Tumors AJCP / REPORTING RECOMMENDATIONS FOR PANCREATIC SPECIMENS CONTAINING MALIGNANT TUMORS Recommendations for the Reporting of Pancreatic Specimens Containing Malignant Tumors Jorge AlboresSaavedra, David

More information

Citation American Journal of Surgery, 196(5)

Citation American Journal of Surgery, 196(5) NAOSITE: Nagasaki University's Ac Title Author(s) Multifocal branch-duct pancreatic i neoplasms Tajima, Yoshitsugu; Kuroki, Tamotsu Amane; Adachi, Tomohiko; Mishima, T Kanematsu, Takashi Citation American

More information

The Future of Cancer. Lawrence Tsui Global Risk Products Actuary Swiss Reinsurance Company Hong Kong. Session Number: WBR8

The Future of Cancer. Lawrence Tsui Global Risk Products Actuary Swiss Reinsurance Company Hong Kong. Session Number: WBR8 Lawrence Tsui Global Risk Products Actuary Swiss Reinsurance Company Hong Kong Session Number: WBR8 Agenda Cancer the basics Cancer past and present Cancer the future CANCER THE BASICS Cancer the basics

More information

5/21/2018. An Update on Pancreas Neoplasms. Arief Suriawinata, M.D. Lines of Differentiation in Pancreatic Neoplasms

5/21/2018. An Update on Pancreas Neoplasms. Arief Suriawinata, M.D. Lines of Differentiation in Pancreatic Neoplasms An Update on Pancreas Neoplasms Arief Suriawinata, M.D. Professor of Pathology and Laboratory Medicine Geisel School of Medicine at Dartmouth Department of Pathology and Laboratory Medicine Dartmouth-Hitchcock

More information

Adenocarcinoma of the pancreas

Adenocarcinoma of the pancreas Adenocarcinoma of the pancreas SEMINARS IN DIAGNOSTIC PATHOLOGY 31 (2014) 443 451 Ralph H.Hruban, MD, David S. Klimstra, MD Paola Parente Anatomia Patologica Casa Sollievo della Sofferenza San Giovanni

More information

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000.

Colorectal adenocarcinoma leading cancer in developed countries In US, annual deaths due to colorectal adenocarcinoma 57,000. Colonic Neoplasia Remotti Colorectal adenocarcinoma leading cancer in developed countries In US, annual incidence of colorectal adenocarcinoma 150,000. In US, annual deaths due to colorectal adenocarcinoma

More information

Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas

Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas Korean J Hepatobiliary Pancreat Surg 2011;15:27-22 Original Article Predictive factors for invasive intraductal papillary mucinous neoplasm of the pancreas Dae Young Jun 1, Hyung Jun Kwon 2, Sang Geol

More information

Case Scenario 1. Discharge Summary

Case Scenario 1. Discharge Summary Case Scenario 1 Discharge Summary A 69-year-old woman was on vacation and noted that she was becoming jaundiced. Two months prior to leaving on that trip, she had had a workup that included an abdominal

More information

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition

Small Intestine. Protocol revision date: January 2005 Based on AJCC/UICC TNM, 6 th edition Small Intestine Protocol applies to all invasive carcinomas of the small intestine, including those with focal endocrine differentiation. Excludes carcinoid tumors, lymphomas, and stromal tumors (sarcomas).

More information

Pancreas composed of 2 parts: 1- exocrine gland 2- endocrine gland

Pancreas composed of 2 parts: 1- exocrine gland 2- endocrine gland pancreas Pancreas composed of 2 parts: 1- exocrine gland 2- endocrine gland Acute pancreatitis Inflammation of the pancreas associated with acinar cell injury Clinical features: 1-abdominal pain cardinal

More information

CODING TUMOUR MORPHOLOGY. Otto Visser

CODING TUMOUR MORPHOLOGY. Otto Visser CODING TUMOUR MORPHOLOGY Otto Visser INTRODUCTION The morphology describes the tissue of the tumour closest to normal tissue Well differentiated tumours are closest to normal Undifferentiated tumours show

More information

Disclosure of Relevant Financial Relationships

Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS

More information

Outline. Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review 4/6/2017. Case Example Background Classification Histology Guidelines

Outline. Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review 4/6/2017. Case Example Background Classification Histology Guidelines Intraductal Papillary Mucinous Neoplasm (IPMN) Guideline Review The Nurse Practitioner Association New York State Capital Region Teaching Day Matthew Warndorf MD Case Example Background Classification

More information

General Surgery PURPLE SERVICE MUHC-RVH Site

General Surgery PURPLE SERVICE MUHC-RVH Site Preamble HPB is a clinical teaching unit with several different vocations: It regroups all solid organ Transplantation as well as most advanced Hepatobiliary and Pancreatic clinical activities performed

More information

Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts

Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts Evaluation of AGA and Fukuoka Guidelines for EUS and surgical resection of incidental pancreatic cysts Authors Alexander Lee 1, Vivek Kadiyala 2,LindaS.Lee 3 Institutions 1 Texas Digestive Disease Consultants,

More information

Evaluation of hereditary syndromes that include pancreatic cancer

Evaluation of hereditary syndromes that include pancreatic cancer Evaluation of hereditary syndromes that include pancreatic cancer UPR CCC 04/12/13 Jeffrey N. Weitzel, M.D. Chief, Division of Clinical Cancer Genetics Cancer Screening & Prevention Program City of Hope

More information

Gastroenterology Tutorial

Gastroenterology Tutorial Gastroenterology Tutorial Gastritis Poorly defined term that refers to inflammation of the stomach. Infection with H. pylori is the most common cause of gastritis. Most patients remain asymptomatic Some

More information

Team approach is essential incorporating: radiology, gastroenterology, surgery and pathology Successful performance is operator dependent

Team approach is essential incorporating: radiology, gastroenterology, surgery and pathology Successful performance is operator dependent Committee V Post Brushing and FNA Testing Managment Options Daniel Kurtycz, M.D. Chair Committee V Committee V - Post brushing and FNA management options Team approach is essential incorporating: radiology,

More information

Genetic testing and pancreatic disease

Genetic testing and pancreatic disease Genetic testing and pancreatic disease February 2 d, 2018 Yale Pancreas Symposium 2018: Multidisciplinary Management of Pancreatic Cancer Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director,

More information

ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts

ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts Grace H. Elta, MD, FACG 1, Brintha K. Enestvedt, MD, MBA 2, Bryan G. Sauer, MD, MSc, FACG (GRADE Methodologist) 3 and Anne Marie Lennon,

More information

Patient History. A 58 year old man presents with a 16 mm cyst in the pancreatic tail. The cyst is unilocular with a thick wall and no mural nodule.

Patient History. A 58 year old man presents with a 16 mm cyst in the pancreatic tail. The cyst is unilocular with a thick wall and no mural nodule. Case 1 Martha Bishop Pitman, MD Director of Cytopathology Massachusetts General Hospital Associate Professor of Pathology Harvard Medical School Boston, MA Patient History A 58 year old man presents with

More information

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY

Colorectal Cancer Structured Pathology Reporting Proforma DD MM YYYY Colorectal Cancer Structured Pathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.03). Family name Given name(s) Date of birth DD MM YYYY S1.02 Clinical details

More information

2014 International Journal of Medical Science Research and Practice available on

2014 International Journal of Medical Science Research and Practice available on International Journal of Medical Science Research and Practice available on www.ijmsrp.com INTERNATIONAL JOURNAL OF MEDICAL SCIENCE RESEARCH AND PRACTICE Print ISSN: 349-3178 Online ISSN: 349-3186 UNIT

More information

Navigators Lead the Way

Navigators Lead the Way RN Navigators Their Role in patients with Cancers of the GI tract Navigators Lead the Way Nurse Navigator Defined Nurse Navigator A clinically trained individual responsible for the identification and

More information

Cancer A Superficial Introduction

Cancer A Superficial Introduction Cancer A Superficial Introduction Gabor Fichtinger, Queen s University Cancer some definitions Medical term: malignant neoplasm Class of diseases in which a group of cells display: uncontrolled growth

More information

Endoscopic Ultrasonography Clinical Impact. Giancarlo Caletti. Gastroenterologia Università di Bologna. Caletti

Endoscopic Ultrasonography Clinical Impact. Giancarlo Caletti. Gastroenterologia Università di Bologna. Caletti Clinical Impact Giancarlo Gastroenterologia Università di Bologna AUSL di Imola,, Castel S. Pietro Terme (BO) 1982 Indications Diagnosis of Submucosal Tumors (SMT) Staging of Neoplasms Evaluation of Pancreato-Biliary

More information

X-ray Corner. Imaging of The Pancreas. Pantongrag-Brown L

X-ray Corner. Imaging of The Pancreas. Pantongrag-Brown L X-ray Corner 125 Imaging of The Pancreas Modern imaging modalities commonly used in pancreas include ultrasound (US), CT, and MRI. Pancreas is a retroperitoneal organ which makes it difficult to visualize

More information

Outcomes Report: Accountability Measures and Quality Improvements

Outcomes Report: Accountability Measures and Quality Improvements Outcomes Report: Accountability Measures and Quality Improvements The FH Memorial Medical Center s Cancer Committee ensures that patients with cancer are treated according to the nationally accepted measures.

More information

Metastatic pancreatic cancer, icd-10

Metastatic pancreatic cancer, icd-10 P ford residence southampton, ny Metastatic pancreatic cancer, icd-10 A cancer diagnosis can be overwhelming. Find out about coping with the emotional, practical and physical effects. Taxanes are conventional

More information

The Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms

The Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms JOP. J Pancreas (Online) 20 Mar 20; (2):-9. RESEARCH ARTICLE The Role of Molecular Analysis in the Diagnosis and Surveillance of Pancreatic Cystic Neoplasms Megan Winner, Amrita Sethi 2, John M Poneros

More information

Colonic Polyp. Najmeh Aletaha. MD

Colonic Polyp. Najmeh Aletaha. MD Colonic Polyp Najmeh Aletaha. MD 1 Polyps & classification 2 Colorectal cancer risk factors 3 Pathogenesis 4 Surveillance polyp of the colon refers to a protuberance into the lumen above the surrounding

More information

BREAST CANCER d an BREAST SELF EXAM

BREAST CANCER d an BREAST SELF EXAM BREAST CANCER and BREAST SELF EXAM American Cancer Society Statistics: 2009 Invasive breast cancer will be diagnosed in over 192,370 women Carcinoma in situ will be diagnosed in 62,280 women More than

More information

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 6 1.5. Primary Tumour Description... 10 1.6.

More information

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval

Biochemistry of Carcinogenesis. Lecture # 35 Alexander N. Koval Biochemistry of Carcinogenesis Lecture # 35 Alexander N. Koval What is Cancer? The term "cancer" refers to a group of diseases in which cells grow and spread unrestrained throughout the body. It is difficult

More information

Biliary cytolgy and pancreatic endoscopic ultrasound-guided FNA. Leena Krogerus Helsinki, FINLAND

Biliary cytolgy and pancreatic endoscopic ultrasound-guided FNA. Leena Krogerus Helsinki, FINLAND Biliary cytolgy and pancreatic endoscopic ultrasound-guided FNA Leena Krogerus Helsinki, FINLAND Reasons for biliary cytology PSC- is a pre-neoplastc condition in youg individulas, the cure of which is

More information

Pancreatic Cystic Neoplasms: Guidelines and beyond

Pancreatic Cystic Neoplasms: Guidelines and beyond Pancreatic Cystic Neoplasms: Guidelines and beyond Kenneth J. Chang, MD, FACG, FASGE Executive Director, Comprehensive Digestive Disease Center Professor and Chief, Gastroenterology Vincent & Anna Kong

More information

CT 101 :Pancreas and Spleen

CT 101 :Pancreas and Spleen CT 101 :Pancreas and Spleen Shikha Khullar,, MD, MPH Division of Radiology University of South Alabama The Pancreas Normal Pancreas 3 Phase Pancreatic CT Non contrast Arterial phase : 30-35 35 second

More information

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Sarah Burton Lead Gynae Oncology Nurse Specialist Cancer Care Cymru Gynaecological Cancers Cervical Cancers Risk factors Presentation Early sexual activity Multiple sexual partners Smoking Human Papiloma

More information

Gastric Cancer Histopathology Reporting Proforma

Gastric Cancer Histopathology Reporting Proforma Gastric Cancer Histopathology Reporting Proforma Mandatory questions (i.e. protocol standards) are in bold (e.g. S1.01). S1.01 Identification Family name Given name(s) Date of birth Sex Male Female Intersex/indeterminate

More information

Chronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases

Chronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases Jichi Medical University Journal Chronic pancreatitis mimicking intraductal papillary mucinous neoplasm of the pancreas; Report of tow cases Noritoshi Mizuta, Hiroshi Noda, Nao Kakizawa, Nobuyuki Toyama,

More information

ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31

ICD-O Morphology code. R=Rare Tier Tumour ICD-O Topography code C30.0, C31 R=Rare Tier Tumour ICD-O Topography code ICD-O Morphology code EPITHELIAL TUMOURS OF NASAL CAVITY AND SINUSES R 2 Squamous cell carcinoma with variants of nasal cavity and sinuses C30.0, C3 C30.0, C3 8000,

More information

*

* Introduction Cancer is complex, can have many possible causes, and is increasingly common. For the U.S. population, 1 in 2 males and 1 in 3 females is at risk of developing cancer in their lifetime. The

More information

Carcinoembryonic Antigen

Carcinoembryonic Antigen Other Names/Abbreviations CEA 190.26 - Carcinoembryonic Antigen Carcinoembryonic antigen (CEA) is a protein polysaccharide found in some carcinomas. It is effective as a biochemical marker for monitoring

More information

Stage 4 gastric adenocarcinoma icd 10

Stage 4 gastric adenocarcinoma icd 10 > Stage 4 gastric adenocarcinoma icd 10 stage iii; Carcinoma of colon, stage iv; Colon cancer metastatic to unspecified site; Hereditary nonpolyposis colon cancer; Malignant tumor of colon; Metastasis.

More information

DOWNLOAD PDF TUMORS OF THE PANCREAS

DOWNLOAD PDF TUMORS OF THE PANCREAS Chapter 1 : Endocrine Tumors of the Pancreas NIDDK This variant of pancreatic cancer is important to recognize because it is associated with a particularly poor prognosis, and in some instances is treated

More information

2018 Texas Cancer Registry Annual Report

2018 Texas Cancer Registry Annual Report 2018 Texas Cancer Registry Annual Report As Required by Texas Health and Safety Code Section 82.007 November 2018 Table of Contents Executive Summary... 1 1. Introduction... 2 2. Background... 3 Cancer

More information

NEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e.

NEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e. NEOPLASIA 1. malignant neoplasms a. are independent of hormonal influence b. are always composed of homogenous cell lines c. arise from differentiated cells by a process of anaplasia d. display abnormal

More information